Dapa Met Xr 5/500 Mg Tablet – Gentle Extended-Release Combo for Type 2 Diabetes
Dapa Met Xr 5/500 Mg Tablet – Gentle Extended-Release Combo for Type 2 Diabetes
Dapa Met Xr 5/500 Mg Tablet – Gentle Extended-Release Combo for Type 2 Diabetes
Description
Dapa Met Xr 5/500 Mg Tablet – Smooth 24-Hour Blood Sugar Control with Proven Heart & Kidney Benefits
Dapa Met Xr 5/500 Mg Tablet combines dapagliflozin 5 mg (SGLT2 inhibitor) with metformin 500 mg in a gentle extended-release formulation to provide steady, all-day glycemic control for adults with type 2 diabetes. The lower doses make it an ideal starting combination or choice for patients sensitive to higher metformin strengths, while still delivering powerful HbA1c reduction, modest weight loss, and clinically proven protection against heart failure and kidney disease progression. Taken just once daily with a meal, it offers excellent tolerability and convenience alongside diet and exercise under medical guidance.
